<DOC>
	<DOCNO>NCT01924065</DOCNO>
	<brief_summary>Patients atrial fibrillation undergo cardioversion randomize undergo transesophageal echocardiography receive warfarin 3 week international normalized ratio ( INR ) value 2.0-3.0 . Those want use warfarin give approve new oral anticoagulant agent istead warfarin 3 week . If thrombus detect left atrium leave atrial appendage , cardioversion perform . Other patient group undergo electrical cardioversion . After procedure patient give oral anticoagulant least 4 Weeks . All patient neurological examination diffusion magnetic resonance imaging ( MRI ) baseline postprocedural 7th day . Clinical subclinical cerebral thromboembolic event detect diffusion MRI record . Any bleeding event period also record .</brief_summary>
	<brief_title>Risk Stroke Silent Cerebrovascular Thromboembolism After Cardioversion Atrial Fibrillation</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thromboembolism</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<criteria>Patients age 18 year plan undergo electrical medical cardioversion Urgent cardioversion Patients implant pacemaker metal device Claustrophobia Hematological disorder enable patient receive anticoagulant agent Atrial fibrillation secondary temporary cause . Serious rheumatic heart valve disease Hyperthyroidism History malignancy Left atrium diameter &gt; 55 mm Ejection fraction &lt; 0.25</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Atrial fibrillation , conversion , stroke</keyword>
</DOC>